🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Raisa I. Krutilina

Tulane University

ORCID: 0000-0002-2118-4019

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling”.

Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0295

N/A

0DataRank · unranked

23 citations

Carlos Perez Kerkvliet, Raisa I. Krutilina, Hilaire C. Playa, Deanna N. Parke, Warner A. Thomas +5 more

HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy

MDPI (MDPI AG)(2021)10.3390/cancers14010027

N/A

0DataRank · unranked

20 citations

Raisa I. Krutilina

HIF-dependent CKB expression promotes breast cancer metastasis, whereas cyclocreatine therapy impairs cellular invasion and improves chemotherapy efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.09.459646

N/A

0DataRank · unranked

4 citations

Hilaire C. Playa, Danielle L. Brooks, Luciana P. Schwab, Deanna N. Parke, Damilola Oluwalana +7 more

Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis

Cancers(2022)10.3390/cancers14215336

N/A

0DataRank · unranked

23 citations

Kelli L. Hartman, Damilola Oluwalana, Hilaire C. Playa, Deanna N. Parke, Hao Chen +4 more

Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0899

N/A

0DataRank · unranked

14 citations

Raisa I. Krutilina, Kelli L. Hartman, Hao Chen, Deanna N. Parke, Rui Wang +8 more

Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4

Endocrinology(2023)10.1210/endocr/bqad083

N/A

0DataRank · unranked

35 citations

Carlos Perez Kerkvliet, Thu H. Truong, Kyla M. Hagen, Raisa I. Krutilina, Deanna N. Parke +6 more

Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer

Cancer Letters(2024)10.1016/j.canlet.2024.217011

N/A

0DataRank · unranked

4 citations

Kelli L. Adeleye, Raisa I. Krutilina, Hao Chen, Hilaire C. Playa, Shanshan Deng +11 more

Discovery of Potent and Brain-Penetrable Tubulin Inhibitors that Effectively Suppress Breast Cancer Brain Metastasis

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0538

N/A

0DataRank · unranked

2 citations

Kelli L. Adeleye, Hilaire C. Playa, Satyanarayana Pochampally, Souvik Banerjee, Damilola Oluwalana +6 more